Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma
NCT05194605 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2022-01-31
Summary
The aim of this study was to developed and validated models to predict therapeutic responses and patients' survivals in patients with osteosarcoma and compared these models with currently available models.
Conditions
Interventions
- OTHER
-
Prediction model
We develop and validate clinical models to predict treatment responses and survival outcomes in patients with biopsy-proven with osteosarcoma.
Sponsors & Collaborators
-
West China Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- China
Study Locations
More Related Trials
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
NCT03451526 ·Status: COMPLETED
-
Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial
NCT06262386 ·Status: RECRUITING ·Phase: NA
-
A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases
NCT03427541 ·Status: UNKNOWN
-
Factors Determining the Prognosis in NSCLC Stage IV
NCT04306094 ·Status: UNKNOWN
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
A Prospective, Observational Trial on the Diagnostic and Prognostic of LM
NCT02607605 ·Status: UNKNOWN
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer
NCT03429192 ·Status: COMPLETED
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival
NCT07100444 ·Status: COMPLETED
-
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
NCT06183762 ·Status: RECRUITING
-
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
NCT07250360 ·Status: COMPLETED
-
Non-small Cell Lung Cancer and Quality of Life
NCT00818402 ·Status: COMPLETED
-
Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer
NCT02250378 ·Status: WITHDRAWN ·Phase: NA
-
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
NCT06494241 ·Status: ACTIVE_NOT_RECRUITING
-
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
NCT03614065 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623 ·Status: COMPLETED
-
Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric Patient
NCT06162962 ·Status: COMPLETED
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma
NCT05185544 ·Status: UNKNOWN
-
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
NCT07256002 ·Status: ACTIVE_NOT_RECRUITING
-
Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis
NCT03363685 ·Status: UNKNOWN
-
Multiomics Tumor Evolution Model of NSCLC
NCT05352035 ·Status: RECRUITING
-
Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective Study
NCT04546243 ·Status: COMPLETED